Dr. Mullins has been with University of Maryland School of Pharmacy for 25 years. His research and teaching focus on community-engaged, patient-centered comparative effectiveness research to advance health equity. In addition to AHRQ, he has also received funding from the National Institute on Aging (NIA), the Patient-Centered Outcomes Research Institute (PCORI), and various pharmaceutical manufacturers including Bayer, Merck, and Pfizer.
“We think about the clinical aspect and social determinants,” said Dr. Mullins. “These are factors that makes it harder for people to be healthy, such as food deserts – healthy foods not in walking distance; and food swamps, abundant access to foods that are not healthy. The reason why we see childhood obesity is because children have abundant access to foods that are not healthy.”
He added, “We don’t want to scare people. However, we want to ensure they are informed by having the information they need, so that they can make healthy choices for themselves. We want people not only to remain on this planet, but to remain on this planet in a healthy state of being. That means low rates of heart attack, early diagnoses of cancer, the ability to solve health problems when patients come to the hospital, so they are not readmitted, and educating people as to why prevention is so much wiser than waiting to get sick and then seeking treatment. The PATIENTS Program provides a way to make all of those things possible.”
For more information about The PATIENTS PROGRAM, visit https://patients.umaryland.edu/